{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:31:16Z","timestamp":1779413476521,"version":"3.53.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cytogenet"],"DOI":"10.1186\/s13039-026-00759-2","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T10:33:44Z","timestamp":1774780424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytogenetic patterns of hematologic malignancies before, during and after the COVID-19 pandemic: a single-center retrospective study in Thailand"],"prefix":"10.1186","volume":"19","author":[{"given":"Montakarn","family":"Tansatit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nutcharee","family":"Jongpornchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwannee","family":"Songchart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kittipornpan","family":"Krajokpap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hudadini","family":"Da-oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"issue":"1","key":"759_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01818-0","volume":"22","author":"A Jaiswal","year":"2024","unstructured":"Jaiswal A, Shrivastav S, Kushwaha HR, Chaturvedi R, Singh RP. Oncogenic potential of SARS-CoV-2-targeting hallmarks of cancer pathways. Cell Commun Signal. 2024;22(1):447.","journal-title":"Cell Commun Signal"},{"issue":"21","key":"759_CR2","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.3390\/cancers15215297","volume":"15","author":"W Wiese","year":"2023","unstructured":"Wiese W, Barczuk J, Racinska O, Siwecka N, Rozpedek-Kaminska W, Slupianek A, et al. PI3K\/Akt\/mTOR Signaling Pathway in Blood Malignancies-New Therapeutic Possibilities. Cancers (Basel). 2023;15(21):5297. https:\/\/doi.org\/10.3390\/cancers15215297.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"759_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138.","journal-title":"Mol Cancer"},{"issue":"3","key":"759_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41422-023-00885-1","volume":"34","author":"AV Ferreira","year":"2024","unstructured":"Ferreira AV, Netea MG. Hematopoietic memory of severe COVID-19 infection. Cell Res. 2024;34(3):187\u20138.","journal-title":"Cell Res"},{"issue":"2","key":"759_CR5","first-page":"117","volume":"16","author":"A Jafarzadeh","year":"2022","unstructured":"Jafarzadeh A, Gosain R, Mortazavi SMJ, Nemati M, Jafarzadeh S, Ghaderi A. SARS-CoV-2 infection: a possible risk factor for incidence and recurrence of cancers. Int J Hematol Oncol Stem Cell Res. 2022;16(2):117\u201327.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"759_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.biochi.2023.05.014","volume":"213","author":"K Jahankhani","year":"2023","unstructured":"Jahankhani K, Ahangari F, Adcock IM, Mortaz E. Possible cancer-causing capacity of COVID-19: is SARS-CoV-2 an oncogenic agent? Biochimie. 2023;213:130\u20138.","journal-title":"Biochimie"},{"issue":"7","key":"759_CR7","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Hematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36(7):1703\u201319.","journal-title":"Leukemia"},{"issue":"7","key":"759_CR8","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Hfematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720\u201348.","journal-title":"Leukemia"},{"issue":"15","key":"759_CR9","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1182\/blood.2021014309","volume":"139","author":"YMN Akkari","year":"2022","unstructured":"Akkari YMN, Baughn LB, Dubuc AM, Smith AC, Mallo M, Dal Cin P, et al. Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood. 2022;139(15):2273\u201384.","journal-title":"Blood"},{"issue":"3","key":"759_CR10","volume":"72","author":"V Lestringant","year":"2024","unstructured":"Lestringant V, Guermouche-Flament H, Jimenez-Pocquet M, Gaillard JB, Penther D. Cytogenetics in the management of hematological malignancies: an overview of alternative technologies for cytogenetic characterization. Curr Res Transl Med. 2024;72(3):103440.","journal-title":"Curr Res Transl Med"},{"key":"759_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2022.108411","volume":"789","author":"P Panico","year":"2022","unstructured":"Panico P, Ostrosky-Wegman P, Salazar AM. The potential role of COVID-19 in the induction of DNA damage. Mutat Res-Rev Mutat Res. 2022;789:108411.","journal-title":"Mutat Res-Rev Mutat Res"},{"key":"759_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1260776","volume":"10","author":"N Ogarek","year":"2023","unstructured":"Ogarek N, Oboza P, Olszanecka-Glinianowicz M, Kocelak P. SARS-CoV-2 infection as a potential risk factor for the development of cancer. Front Mol Biosci. 2023;10:1260776.","journal-title":"Front Mol Biosci"},{"issue":"10","key":"759_CR13","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3390\/vaccines10101607","volume":"10","author":"V Rapti","year":"2022","unstructured":"Rapti V, Tsaganos T, Vathiotis IA, Syrigos NK, Li P, Poulakou G. New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge? Vaccines (Basel). 2022;10(10):1607. https:\/\/doi.org\/10.3390\/vaccines10101607.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"759_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.htct.2021.11.015","volume":"44","author":"BA Costa","year":"2022","unstructured":"Costa BA, da Luz KV, Campos SEV, Lopes GS, Leitao JPV, Duarte FB. Can SARS-CoV-2 induce hematologic malignancies in predisposed individuals? A case series and review of the literature. Hematol Transfus Cell Ther. 2022;44(1):26\u201331.","journal-title":"Hematol Transfus Cell Ther"},{"key":"759_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbrc.2021.09.024","volume":"579","author":"J Victor","year":"2021","unstructured":"Victor J, Deutsch J, Whitaker A, Lamkin EN, March A, Zhou P, et al. SARS-CoV-2 triggers DNA damage response in Vero E6 cells. Biochem Biophys Res Commun. 2021;579:141\u20135.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Molecular Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13039-026-00759-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-026-00759-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-026-00759-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:01:10Z","timestamp":1779411670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13039-026-00759-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["759"],"URL":"https:\/\/doi.org\/10.1186\/s13039-026-00759-2","relation":{},"ISSN":["1755-8166"],"issn-type":[{"value":"1755-8166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}